Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells

Biochemical Pharmacology
Shilpa TyagiYogeshwer Shukla

Abstract

Polo-like kinase 1 (Plk1), a critical regulator of mitotic entry, progression and exit, has been shown to be involved in a variety of cancers and thus is becoming an attractive target for cancer management. In case of DNA damage, Plk1 not only inhibits p53 independent apoptosis by dysfunctioning p73α but also allows cells to recover from growth arrest. Here, we showed the effects of knocking down plk1 gene through small interference RNA (siRNA) on cell cycle progression, proliferation and chemosensitivity of p53 mutant A431 cells to cisplatin (CDDP). The expression of Plk1 was measured by RT-PCR and Western blotting. Anti-proliferative response accompanied with cell cycle arrest in G(2)/M phase and induction of cell death was recorded following Plk1 knockdown. Furthermore, cells following knockdown of Plk1, which induced increase of Cyclin B1, p-Cdc2 and p73α with a decrease in p-Cdc25C, were more sensitive to CDDP. CDDP treatment induced nuclear translocation and co-localization of Plk1 with p73α whereas combination of CDDP and Plk1siRNA upregulated the expression of p73α protein in a synergistic manner thereby leading to an increase up to ∼5 folds in CDDP-induced cell death. The increase in caspase-3 activity indicated apopto...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Jun 1, 1992·Current Opinion in Oncology·V K Hamasaki, E E Vokes
Oct 1, 1990·American Journal of Clinical Oncology·D J AdelsteinJ D Hines
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea PaceLoredana Bove
Apr 4, 2003·Nutrition and Cancer·Annu Arora, Yogeshwer Shukla
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqi Liu, Raymond L Erikson
Oct 25, 2003·Oncogene·Wafik S El-Deiry
Apr 20, 2004·Cellular and Molecular Life Sciences : CMLS·K HarmsX Chen
Jun 3, 2004·Journal of the National Cancer Institute·Birgit SpänkuchKlaus Strebhardt
Jan 11, 2005·Oncogene·Noriyuki TakaiIsao Miyakawa
Aug 17, 2005·Cancer Research·Marcel A T M van VugtRené H Medema
Nov 8, 2005·Cancer Science·Toshinori Ozaki, Akira Nakagawara
Jan 28, 2006·World Journal of Gastroenterology : WJG·Xue-Hua ChenZheng-Gang Zhu
Mar 2, 2006·Molecular and Cellular Biology·Xiaoqi LiuRaymond L Erikson
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·M LokshinC Prives
Feb 3, 2007·Molecular Cancer Therapeutics·Timothy J LansingMui Cheung
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Klaus MrossGerd Munzert
Aug 5, 2009·Cell Cycle·Travis L SchmitNihal Ahmad
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yan Degenhardt, Thomas Lampkin
Mar 4, 2010·International Journal of Oncology·Soo-A KimSang-Gun Ahn

❮ Previous
Next ❯

Citations

Aug 9, 2011·Nature Cell Biology·David F KashatusChristopher M Counter
Nov 9, 2011·The International Journal of Biochemistry & Cell Biology·Zhao-Xia WangYong-Mei Yin
Apr 16, 2013·Current Opinion in Pharmacology·Elena Doménech, Marcos Malumbres
Sep 13, 2011·Acta Biochimica Et Biophysica Sinica·Luqing ZhaoYa Cao
Nov 27, 2016·Translational Oncology·Zhixian LiuXiaosheng Wang
Oct 19, 2017·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Da YaoYouhui Qian
May 4, 2016·Medicinal Research Reviews·J Van den BosscheA Wouters
Nov 30, 2018·Journal of Cellular Physiology·Zihao ChenHongping Ju

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis